Articles

A William Blair analyst cheers Nvidia’s moat and margins — while also weighing in positively on Broadcom and Arm shares.

GM offering an approved NACS DC adapter for purchase through its apps.

The Bank of England unlikely to join peers in cutting rates this month as it’s stymied by stubborn service sector inflation.

Construction on new U.S. homes rose 9.6% in August, the Commerce Department said Wednesday.

A giddy Wall Street projects the Federal Reserve will dramatically reduce interest rates over the next year, even though the U.S. economy seems to be growing rapidly. Odd? Not at all, economists say.

Gold miners have started to see their performances compared to gold improve in 2024 so far

Is anyone paying attention?

John Paulson, the investor who successfully bet against the subprime-mortgage bubble, said he would withdraw his money from the market if Vice President Kamala Harris wins in November.

Merck & Co. Inc. said Wednesday the U.S. Food and Drug Administration has approved its blockbuster cancer drug Keytruda as a treatment for malignant plural mesothelioma, a rare cancer associated with asbestos.

Oil futures fell Wednesday, feeling pressure after industry data showed a rise in U.S. crude and product inventories as investors awaited an expected Federal Reserve rate cut.

The directors said the decision comes after months of work that failed to result in an actionable plan that meets the interests of non-affiliated shareholders.

The Fed’s interest-rate cuts will soften the prices consumers pay for debt — but people may not see an impact on their payments for a while.